996 Combination therapy of peginterferon alfa-2A (40KD) (PEGASYS(R)) and ribavirin (COPEGUS(R)) significantly enhance sustained virological and biochemical response rate in chronic hepatitis C genotype 4 patients in Saudi Arabia

Journal article

Peer reviewed

O Shobokshi, F Serebour, L Skakni, N Aljasser, A Tantawi, A Sabah, T Dinish, M Alquaiz, K Qahtani and A Sandokji

Hepatology (Baltimore, Md.), Vol.38, pp.636-636

2003

Metrics

1 Record Views

Title: 996 Combination therapy of peginterferon alfa-2A (40KD) (PEGASYS(R)) and ribavirin (COPEGUS(R)) significantly enhance sustained virological and biochemical response rate in chronic hepatitis C genotype 4 patients in Saudi Arabia
Creators - without role: O Shobokshi
F Serebour
L Skakni
N Aljasser
A Tantawi
A Sabah
T Dinish
M Alquaiz
K Qahtani
A Sandokji
Publication Details: Hepatology (Baltimore, Md.), Vol.38, pp.636-636
Identifiers: 9929800008331
Academic Unit: Taibah University
Language: English
Resource Type: Journal article